{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:08:42Z","timestamp":1788390522554,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jvir.2024.12.596","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T20:31:31Z","timestamp":1736454691000},"page":"641-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and Effectiveness of Yttrium-90 Radioembolization in People Living with Human Immunodeficiency Virus"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4589-4661","authenticated-orcid":false,"given":"Kartikeya M.","family":"Menon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9521-0160","authenticated-orcid":false,"given":"Ricki A.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Marron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8389-2387","authenticated-orcid":false,"given":"Jack","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Bishay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirema","family":"Garcia-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2024.12.596_bib1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvir.2024.12.596_bib2","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1245\/s10434-020-09414-5","article-title":"Optimizing the combination of immunotherapy and trans-arterial locoregional therapy for stages B and C hepatocellular cancer","volume":"28","author":"Woeste","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2024.12.596_bib3","first-page":"1257","article-title":"Hepatocellular carcinoma in HIV positive patients","volume":"16","author":"Nunnari","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jvir.2024.12.596_bib4","first-page":"4","article-title":"Immune control of HIV","volume":"1","author":"Balasubramaniam","year":"2019","journal-title":"J\u00a0Life Sci (Westlake Village)"},{"key":"10.1016\/j.jvir.2024.12.596_bib5","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1097\/QAD.0b013e32831103ad","article-title":"Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma","volume":"22","author":"Clifford","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jvir.2024.12.596_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00001622-200209000-00011","article-title":"Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients","volume":"14","author":"Smukler","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jvir.2024.12.596_bib7","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2024.12.596_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9270(00)02167-5","article-title":"Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C","volume":"96","author":"Garc\u00eda-Samaniego","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvir.2024.12.596_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/gut.2008.163287","article-title":"gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis","volume":"59","author":"Bruno","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jvir.2024.12.596_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAI.0000000000000842","article-title":"A\u00a0systematic review of the inclusion (or exclusion) of women in HIV research: from clinical studies of antiretrovirals and vaccines to cure strategies","volume":"71","author":"Curno","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jvir.2024.12.596_bib11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/bjc.2015.301","article-title":"The exclusion of people living with HIV (PLWH) from clinical trials in lymphoma","volume":"113","author":"Venturelli","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jvir.2024.12.596_bib12","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1200\/JCO.2017.73.7338","article-title":"Modernizing clinical trial eligibility criteria: recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group","volume":"35","author":"Uldrick","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"Supplement 1","key":"10.1016\/j.jvir.2024.12.596_bib13","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1002\/lt.20036","article-title":"Hepatic arterial 90yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients","volume":"10","author":"Carr","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jvir.2024.12.596_bib14","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/01.RVI.0000184594.01661.81","article-title":"Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival","volume":"16","author":"Salem","year":"2005","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.12.596_bib15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00270-020-02467-9","article-title":"Lymphocytes and neutrophil-to-lymphocyte ratio variations after selective internal radiation treatment for HCC: a retrospective cohort study","volume":"43","author":"Estrade","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2024.12.596_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/JHC.S350219","article-title":"Dynamic lymphocyte changes following transarterial radioembolization: association with normal liver dose and effect on overall survival","volume":"9","author":"Young","year":"2022","journal-title":"J\u00a0Hepatocell Carcinoma"},{"key":"10.1016\/j.jvir.2024.12.596_bib17","author":"Nunez"},{"key":"10.1016\/j.jvir.2024.12.596_bib18","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1097\/QAD.0000000000003956","article-title":"Longitudinal viral load outcomes of adults with HIV after detectable viremia on tenofovir, lamivudine, and dolutegravir","volume":"38","author":"Sodeke","year":"2024","journal-title":"AIDS"},{"key":"10.1016\/j.jvir.2024.12.596_bib19","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression ompared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2024.12.596_bib20","doi-asserted-by":"crossref","first-page":"12311","DOI":"10.3748\/wjg.v21.i43.12311","article-title":"Role of liver transplantation in human immunodeficiency virus positive patients","volume":"21","author":"Joshi","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jvir.2024.12.596_bib21","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.29691","article-title":"Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience","volume":"68","author":"Salem","year":"2018","journal-title":"Hepatology"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044325000041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044325000041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T15:16:38Z","timestamp":1744384598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044325000041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1051044325000041"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2024.12.596","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Effectiveness of Yttrium-90 Radioembolization in People Living with Human Immunodeficiency Virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2024.12.596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2025","name":"copyright","label":"Copyright"}]}}